BNP Paribas Financial Markets
CSBR icon

BNP Paribas Financial Markets’s Champions Oncology CSBR Stock Holding History

BNP Paribas Financial Markets’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45
Closed -$459 – 4213
2021
Q3 		$459 Sell
45
-1,429
-97% -$14.5K ﹤0.01% 3926
2021
Q2 		$15.2K Buy
1,474
+701
+91% +$7.11K ﹤0.01% 3617
2021
Q1 		$8.73K Sell
773
-194
-20% -$2.25K ﹤0.01% 3836
2020
Q4 		$10.4K Sell
967
-485
-33% -$5K ﹤0.01% 3922
2020
Q3 		$13.4K Buy
1,452
+1,182
+438% +$10.5K ﹤0.01% 3919
2020
Q2 		$2.58K Buy
+270
New +$2.3K ﹤0.01% 4154

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

BNP Paribas Financial Markets's CSBR Position: Q4 2021 in Review

BNP Paribas Financial Markets sold out of Champions Oncology (CSBR) in Q4 2021, closing a stake of 45 shares — an estimated $459 sold.

BNP Paribas Financial Markets first reported a position in CSBR in Q2 2020 and held it in 6 quarters. The position peaked at $15.2K in Q2 2021. 31 funds tracked by Wall St. Rank hold CSBR as of Q4 2021.

  • BNP Paribas Financial Markets reported no remaining Champions Oncology position as of Q4 2021 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 45 Champions Oncology shares in Q4 2021, an estimated $459.
  • BNP Paribas Financial Markets first reported a position in Champions Oncology in Q2 2020 and held it in 6 quarters.
  • BNP Paribas Financial Markets's Champions Oncology position peaked at $15.2K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2021.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2021, filed 9 Feb 2022.